ARNASA Study -A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Genentech, Inc.
Start Date
March 7, 2024
End Date
September 17, 2024
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Genentech, Inc.
Start Date
March 7, 2024
End Date
September 17, 2024